|
1
|
Brenner H, Rothenbacher D and Arndt V:
Epidemiology of stomach cancer. Methods Mol Biol. 472:467–477.
2009. View Article : Google Scholar
|
|
2
|
Du C, Zhou Y, Cai H, Zhao G, Fu H and Shi
YQ: Poor prognostic factors in patients with stage I gastric cancer
according to the seventh edition TNM classification: a comparative
analysis of three subgroups. J Surg Oncol. 105:323–328. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lazar D, Taban S, Sporea I, et al: Gastric
cancer: correlation between clinicopathological factors and
survival of patients (III). Rom J Morphol Embryol. 50:369–379.
2009.PubMed/NCBI
|
|
4
|
Lazar D, Taban S, Sporea I, et al: Gastric
cancer: correlation between clinicopathological factors and
survival of patients. II. Rom J Morphol Embryol. 50:185–194.
2009.PubMed/NCBI
|
|
5
|
Macias H, Moran A, Samara Y, et al:
SLIT/ROBO1 signaling suppresses mammary branching morphogenesis by
limiting basal cell number. Dev Cell. 20:827–840. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Georgas K, Burridge L, Smith K, et al:
Assignment of the human slit homologue SLIT2 to human chromosome
band 4p15.2. Cytogenet Cell Genet. 86:246–247. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jia L, Cheng L and Raper J: Slit/Robo
signaling is necessary to confine early neural crest cells to the
ventral migratory pathway in the trunk. Dev Biol. 282:411–421.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wong K, Park HT, Wu JY and Rao Y: Slit
proteins: molecular guidance cues for cells ranging from neurons to
leukocytes. Curr Opin Genet Dev. 12:583–591. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Goldberg D, Borojevic R, Anderson M, Chen
JJ, Gershon MD and Ratcliffe EM: Slit/Robo-mediated chemorepulsion
of vagal sensory axons in the fetal gut. Dev Dyn. 242:9–15. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mitra S, Mazumder-Indra D, Mondal RK, et
al: Inactivation of SLIT2-ROBO1/2 pathway in premalignant lesions
of uterine cervix: clinical and prognostic significances. PLoS One.
7:e383422012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dong R, Yu J, Pu H, Zhang Z and Xu X:
Frequent SLIT2 promoter methylation in the serum of patients with
ovarian cancer. J Int Med Res. 40:681–686. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Alvarez C, Tapia T, Cornejo V, et al:
Silencing of tumor suppressor genes RASSF1A, SLIT2,
and WIF1 by promoter hypermethylation in hereditary breast
cancer. Mol Carcinog. 52:475–487. 2012.
|
|
13
|
Jin J, You H, Yu B, et al: Epigenetic
inactivation of SLIT2 in human hepatocellular carcinomas. Biochem
Biophys Res Commun. 379:86–91. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dallol A, Morton D, Maher ER and Latif F:
SLIT2 axon guidance molecule is frequently inactivated in
colorectal cancer and suppresses growth of colorectal carcinoma
cells. Cancer Res. 63:1054–1058. 2003.PubMed/NCBI
|
|
15
|
Dunwell TL, Dickinson RE, Stankovic T, et
al: Frequent epigenetic inactivation of the SLIT2 gene in chronic
and acute lymphocytic leukemia. Epigenetics. 4:265–269. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Singh RK, Indra D, Mitra S, et al:
Deletions in chromosome 4 differentially associated with the
development of cervical cancer: evidence of slit2 as a candidate
tumor suppressor gene. Hum Genet. 122:71–81. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ma S, Liu X, Geng JG and Guo SW: Increased
SLIT immunoreactivity as a biomarker for recurrence in endometrial
carcinoma. Am J Obstet Gynecol. 202:68.e61–68.e11. 2010.PubMed/NCBI
|
|
18
|
Shen F, Liu X, Geng JG and Guo SW:
Increased immunoreactivity to SLIT/ROBO1 in ovarian endometriomas:
a likely constituent biomarker for recurrence. Am J Pathol.
175:479–488. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Prasad A, Paruchuri V, Preet A, Latif F
and Ganju RK: Slit-2 induces a tumor-suppressive effect by
regulating β-catenin in breast cancer cells. J Biol Chem.
283:26624–26633. 2008.PubMed/NCBI
|
|
20
|
Chen WF, Gao WD, Li QL, Zhou PH, Xu MD and
Yao LQ: SLIT2 inhibits cell migration in colorectal cancer through
the AKT-GSK3β signaling pathway. Int J Colorectal Dis. Jan
13–2013.(Epub ahead of print).
|
|
21
|
Liu X, Lu Y, Zhang Y, et al: Slit2
regulates the dispersal of oligodendrocyte precursor cells via
Fyn/RhoA signaling. J Biol Chem. 287:17503–17516. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hofmeister W, Devine CA, Rothnagel JA and
Key B: Frizzled-3a and slit2 genetically interact to
modulate midline axon crossing in the telencephalon. Mech Dev.
129:109–124. 2012. View Article : Google Scholar
|
|
23
|
Sinicrope FA, Ruan SB, Cleary KR, Stephens
LC, Lee JJ and Levin B: bcl-2 and p53 oncoprotein expression during
colorectal tumorigenesis. Cancer Res. 55:237–241. 1995.PubMed/NCBI
|
|
24
|
Chang PH, Hwang-Verslues WW, Chang YC, et
al: Activation of Robo1 signaling of breast cancer cells by Slit2
from stromal fibroblast restrains tumorigenesis via blocking
PI3K/Akt/β-catenin pathway. Cancer Res. 72:4652–4661.
2012.PubMed/NCBI
|
